Inventor · disambiguated record
Richard A. Heyman
Also filed as: HEYMAN RICHARD A · HEYMAN RICHARD ALAN
24 granted patents·5 pending applications·597 citations·filing 1990–2008
97Inventor score
Files withLIGAND PHARM INC14SALK INST FOR BIOLOGICAL STUDI9LAMPH WILLIAM W2BOEHM MARCUS F1EISAI INC1
Top patents by PatentIndex Score
29 records- 0195US5780676ACompounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X ReceptorsLIGAND PHARM INC·Filed 1995·Granted Jul 14, 1998·81 cites·23 claims
- 0289US5962731ACompounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1995·Granted Oct 5, 1999·30 cites·26 claims
- 0385US6028052ATreating NIDDM with RXR agonistsLIGAND PHARM INC·Filed 1996·Granted Feb 22, 2000·49 cites·162 claims
- 0485US5668175AUse of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoidsSALK INST FOR BIOLOGICAL STUDI·Filed 1996·Granted Sep 16, 1997·76 cites·5 claims
- 0584US6096787AUse of selective ligands for treatment of disease states responsive to steroid or steroid-like hormonesSALK INST FOR BIOLOGICAL STUDI·Filed 1997·Granted Aug 1, 2000·66 cites·8 claims
- 0683US6521633B2Treating NIDDM with RXR agonistsLIGAND PHARM INC·Filed 2001·Granted Feb 18, 2003·9 cites·1 claims
- 0783US6316404B1Treating NIDDM with RXR agonistsLIGAND PHARM INC·Filed 2000·Granted Nov 13, 2001·9 cites·15 claims
- 0878US6043279ACompounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1997·Granted Mar 28, 2000·16 cites·13 claims
- 0978US5972881ATreating NIDDM with RXR agonistsLIGAND PHARM INC·Filed 1997·Granted Oct 26, 1999·32 cites·47 claims
- 1076US7056954B2Means for the modulation of processes mediated by retinoid receptors and compounds useful thereforLIGAND PHARM INC·Filed 2003·Granted Jun 6, 2006·3 cites·2 claims
- 1176US5990163ASelective modulation of processes mediated by retinoid X receptors, and compounds useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Nov 23, 1999·51 cites·16 claims
- 1267US5602009ADominant negative chimeras of the steroid/thyroid superfamily of receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 1990·Granted Feb 11, 1997·25 cites·20 claims
- 1366US6545049B1Dimer-selective RXR modulators and methods for their useLIGAND PHARM INC·Filed 1999·Granted Apr 8, 2003·22 cites·36 claims
- 1465US6610883B1Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1998·Granted Aug 26, 2003·9 cites·17 claims
- 1563US2006211768A1Means for the modulation of processes mediated by retinoid receptors and compounds useful thereforLIGAND PHARM INC·Filed 2005·Application pending·0 cites
- 1662US7655699B1Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsEISAI INC·Filed 1993·Granted Feb 2, 2010·24 cites·17 claims
- 1761US6320074B1Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptorsLIGAND PHARM INC·Filed 1998·Granted Nov 20, 2001·18 cites·41 claims
- 1860US6506917B1Compounds and compositions useful for modulation of processes mediated by RXRSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Jan 14, 2003·18 cites·26 claims
- 1957US6228862B1Treating NIDDM with RXR agonistsLIGAND PHARM INC·Filed 1999·Granted May 8, 2001·11 cites·1 claims
- 2057US5968989AMeans for the modulation of processes mediated by retinoid receptors and compounds useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Oct 19, 1999·17 cites·28 claims
- 2156US7259188B2Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulatorsLLGAND PHARMACEUTICALS INC·Filed 2002·Granted Aug 21, 2007·2 cites·18 claims
- 2254US2009093546A1Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR ModulatorsLAMPH WILLIAM W·Filed 2008·Application pending·0 cites
- 2352US5932622AMethod for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acidSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Aug 3, 1999·14 cites·2 claims
- 2451US2006106072A1Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X ReceptorsBOEHM MARCUS F·Filed 2005·Application pending·0 cites
- 2550US2007238791A1Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulatorsLAMPH WILLIAM W·Filed 2007·Application pending·0 cites
- 2646US6677311B1Inducible HSV-TK in transformed cell populationsSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Jan 13, 2004·11 cites·18 claims
- 2746US2004019072A1Dimer-selective RXR modulators and methods for their useFiled 2003·Application pending·0 cites
- 2840US6576676B1Means for the modulation of processes mediated by retinold receptors and compounds useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 1999·Granted Jun 10, 2003·4 cites·1 claims
- 2931US6992108B1Means for the modulation of processes mediated by retinoid receptors and compounds useful thereforLIGAND PHARM INC·Filed 1995·Granted Jan 31, 2006·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Richard A. Heyman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →